» Articles » PMID: 28649398

Ecological Networking of Cystic Fibrosis Lung Infections

Overview
Date 2017 Jun 27
PMID 28649398
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

In the context of a polymicrobial infection, treating a specific pathogen poses challenges because of unknown consequences on other members of the community. The presence of ecological interactions between microbes can change their physiology and response to treatment. For example, in the cystic fibrosis lung polymicrobial infection, antimicrobial susceptibility testing on clinical isolates is often not predictive of antibiotic efficacy. Novel approaches are needed to identify the interrelationships within the microbial community to better predict treatment outcomes. Here we used an ecological networking approach on the cystic fibrosis lung microbiome characterized using 16S rRNA gene sequencing and metagenomics. This analysis showed that the community is separated into three interaction groups: Gram-positive anaerobes, and . The and groups both anti-correlate with the anaerobic group, indicating a functional antagonism. When patients are clinically stable, these major groupings were also stable, however, during exacerbation, these communities fragment. Co-occurrence networking of functional modules annotated from metagenomics data supports that the underlying taxonomic structure is driven by differences in the core metabolism of the groups. Topological analysis of the functional network identified the non-mevalonate pathway of isoprenoid biosynthesis as a keystone for the microbial community, which can be targeted with the antibiotic fosmidomycin. This study uses ecological theory to identify novel treatment approaches against a polymicrobial disease with more predictable outcomes.

Citing Articles

Keystone bacteria dynamics in chronic obstructive pulmonary disease (COPD): Towards differential diagnosis and probiotic candidates.

KavianFar A, Taherkhani H, Lanjanian H, Aminnezhad S, Ahmadi A, Azimzadeh S Heliyon. 2025; 11(4):e42719.

PMID: 40040961 PMC: 11876909. DOI: 10.1016/j.heliyon.2025.e42719.


Metagenomics Applied to the Respiratory Mycobiome in Cystic Fibrosis.

Angebault C, Botterel F Mycopathologia. 2024; 189(5):82.

PMID: 39264513 PMC: 11392981. DOI: 10.1007/s11046-024-00887-6.


Globally distributed bacteriophage genomes reveal mechanisms of tripartite phage-bacteria-coral interactions.

Wallace B, Varona N, Hesketh-Best P, Stiffler A, Silveira C ISME J. 2024; 18(1).

PMID: 39030686 PMC: 11309003. DOI: 10.1093/ismejo/wrae132.


Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis.

Widder S, Carmody L, Opron K, Kalikin L, Caverly L, LiPuma J Nat Commun. 2024; 15(1):4889.

PMID: 38849369 PMC: 11161516. DOI: 10.1038/s41467-024-49150-y.


Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis.

Widder S, Carmody L, Opron K, Kalikin L, Caverly L, LiPuma J Res Sq. 2024; .

PMID: 38562856 PMC: 10984025. DOI: 10.21203/rs.3.rs-4128740/v1.


References
1.
Lewontin R . The meaning of stability. Brookhaven Symp Biol. 1969; 22:13-24. View

2.
Berry D, Widder S . Deciphering microbial interactions and detecting keystone species with co-occurrence networks. Front Microbiol. 2014; 5:219. PMC: 4033041. DOI: 10.3389/fmicb.2014.00219. View

3.
Friedman J, Alm E . Inferring correlation networks from genomic survey data. PLoS Comput Biol. 2012; 8(9):e1002687. PMC: 3447976. DOI: 10.1371/journal.pcbi.1002687. View

4.
Irie Y, OToole G, Yuk M . Pseudomonas aeruginosa rhamnolipids disperse Bordetella bronchiseptica biofilms. FEMS Microbiol Lett. 2005; 250(2):237-43. DOI: 10.1016/j.femsle.2005.07.012. View

5.
Sibley C, Surette M . The polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal Lecture. Can J Microbiol. 2011; 57(2):69-77. DOI: 10.1139/w10-105. View